Srs Capital Advisors, Inc. Gossamer Bio, Inc. Transaction History
Srs Capital Advisors, Inc.
- $8.6 Billion
- Q3 2025
A detailed history of Srs Capital Advisors, Inc. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 10,859 shares of GOSS stock, worth $29,427. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,859Holding current value
$29,427% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GOSS
# of Institutions
182Shares Held
163MCall Options Held
8.11MPut Options Held
211K-
Nea Management Company, LLC Timonium, MD18.1MShares$49 Million2.97% of portfolio
-
Octagon Capital Advisors LP New York, NY17.1MShares$46.2 Million14.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$32.5 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$21.8 Million9.24% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.13MShares$16.6 Million6.11% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $255M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...